Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Sixfold Bioscience's investors include Y Combinator, Cantos, Bossa Invest, Innovate UK, European Commission.
Sixfold Bioscience is headquartered in London, United Kingdom.
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Sixfold Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sixfold Bioscience — Funding & Investors." VCBacked, December 2, 2021, https://www.vcbacked.co/company/sixfold-bioscience. Accessed November 14, 2026.
VCBacked. (2021). Sixfold Bioscience — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/sixfold-bioscience
{{cite web |title=Sixfold Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/sixfold-bioscience |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sixfold Bioscience? Request a listing update